Childhood Absence Epilepsy with Generalized Tonic-Clonic Seizures: What to Do When Prior Combination Therapy Has Not Achieved Seizure Freedom

Clinical scenario

This protocol is for children with childhood absence epilepsy (CAE) who have also experienced a generalized tonic-clonic seizure. The co-occurrence of this seizure type is clinically significant because it limits which antiseizure therapies are appropriate — not all agents effective for absence seizures provide coverage against generalized tonic-clonic events.

Prior treatment — failure condition

The preceding treatment line used either a combination of valproic acid and lamotrigine together, or clobazam as monotherapy. The goal of that line was freedom from absence seizures. This protocol applies when that goal was not met — that is, absence seizures persist despite the previous regimen.

Next-line approach (partial overview)

When the prior combination or monotherapy approach has not controlled absence seizures, the next step involves consideration of specific oral antiseizure agents or a specialised dietary intervention. The complete criteria for selecting among these options, including the full clinical conditions, are available in the structured protocol.

Target: freedom from absence seizures

Instant Access to Structured Evidence-Based Regimens

References

VPA is the drug of choice as initial monotherapy in CAE when a generalized tonic–clonic seizure has occurred, because ETX is not effective against seizure types beyond absence seizures.

Although the evidence for efficacy in CAE is scant and variably supportive, topiramate and zonisamide may be considered when other treatments fail.

The ketogenic diet has also been used successfully in children with treatment-resistant CAE.

View source ↗